Weijing Li

1.9k total citations
66 papers, 1.5k citations indexed

About

Weijing Li is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Global and Planetary Change. According to data from OpenAlex, Weijing Li has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Public Health, Environmental and Occupational Health, 20 papers in Hematology and 20 papers in Global and Planetary Change. Recurrent topics in Weijing Li's work include Acute Lymphoblastic Leukemia research (28 papers), Climate variability and models (18 papers) and Childhood Cancer Survivors' Quality of Life (16 papers). Weijing Li is often cited by papers focused on Acute Lymphoblastic Leukemia research (28 papers), Climate variability and models (18 papers) and Childhood Cancer Survivors' Quality of Life (16 papers). Weijing Li collaborates with scholars based in China, United States and Canada. Weijing Li's co-authors include Jinqing Zuo, Chenghu Sun, Hong‐Li Ren, Ruonan Zhang, Lei Cui, Renhe Zhang, Chao Gao, Xiaoxi Zhao, Li Xu and Zhigang Li and has published in prestigious journals such as Blood, Scientific Reports and Journal of Climate.

In The Last Decade

Weijing Li

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijing Li China 22 761 742 318 256 224 66 1.5k
Marina Baldi Italy 22 909 1.2× 816 1.1× 194 0.6× 35 0.1× 101 0.5× 70 2.1k
Chloé Prodhomme France 21 713 0.9× 546 0.7× 79 0.2× 30 0.1× 246 1.1× 56 1.0k
Thomas Williams United States 21 98 0.1× 81 0.1× 169 0.5× 867 3.4× 111 0.5× 60 2.3k
Sabine Haase Germany 13 143 0.2× 176 0.2× 38 0.1× 196 0.8× 60 0.3× 27 940
R. Higgins United Kingdom 18 256 0.3× 52 0.1× 74 0.2× 70 0.3× 31 0.1× 45 1.0k
Jieqiong Zhou China 20 67 0.1× 154 0.2× 59 0.2× 28 0.1× 121 0.5× 67 1.2k
David A. Waugh United States 23 88 0.1× 60 0.1× 20 0.1× 124 0.5× 177 0.8× 55 1.4k
Yan Ding United States 18 141 0.2× 187 0.3× 40 0.1× 14 0.1× 242 1.1× 36 1.3k
Michael Rothe Germany 23 232 0.3× 179 0.2× 17 0.1× 66 0.3× 9 0.0× 80 1.5k

Countries citing papers authored by Weijing Li

Since Specialization
Citations

This map shows the geographic impact of Weijing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Li more than expected).

Fields of papers citing papers by Weijing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Li. The network helps show where Weijing Li may publish in the future.

Co-authorship network of co-authors of Weijing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weijing Li. A scholar is included among the top collaborators of Weijing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijing Li. Weijing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Weijing, Jun-Chieh J. Tsay, Chung‐Ming Huang, et al.. (2025). Hydroxychloroquine enhances efferocytosis and modulates inflammation via MerTK/Gas6 signaling in a pristane-induced lupus mouse model. Frontiers in Immunology. 16. 1524315–1524315.
2.
Lian, Hongyun, Weijing Li, Qing Zhang, et al.. (2024). The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis. Jornal de Pediatria. 101(2). 194–201.
4.
Li, Weijing, Shuguang Liu, Chanjuan Wang, et al.. (2023). DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells. BMC Cancer. 23(1). 255–255. 2 indexed citations
5.
Wang, Yong, et al.. (2023). Accuracy of closed-loop and open-loop propofol delivery systems by bispectral index monitoring in breast surgery patients: a prospective randomized trial. Brazilian Journal of Anesthesiology (English Edition). 74(2). 744438–744438.
6.
Li, Weijing, Chanjuan Wang, Qing Zhang, et al.. (2023). Tracing back of relapse clones by Ig/TCR gene rearrangements reveals complex patterns of recurrence in pediatric acute lymphoblastic leukemia. International Journal of Laboratory Hematology. 45(5). 717–725.
8.
Li, Weijing, Chih‐Yi Liao, Szu‐Hao Kung, et al.. (2022). A Reverse Mutation E143K within the PrM Protein of Zika Virus Asian Lineage Natal RGN Strain Increases Infectivity and Cytopathicity. Viruses. 14(7). 1572–1572. 7 indexed citations
9.
Huang, Chen, Ruixia Liu, Huichao Zhang, et al.. (2022). Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma. Frontiers in Immunology. 13. 983934–983934. 5 indexed citations
10.
Wang, Chanjuan, Lei Cui, Honghao Ma, et al.. (2021). BRAF V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis. Molecular Cancer Therapeutics. 20(7). 1316–1323. 4 indexed citations
11.
Zhang, Qing, Ang Wei, Honghao Ma, et al.. (2020). A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis. Haematologica. 106(7). 1892–1901. 43 indexed citations
12.
13.
Zhang, Ruonan, Renhe Zhang, Zhiyan Zuo, & Weijing Li. (2015). Temporal and spatial features and inter‐annual variability of wintertime snow mass balance over China. International Journal of Climatology. 36(12). 3897–3907. 7 indexed citations
14.
Zhang, Han, Hao Cheng, Qingqing Wang, et al.. (2015). An advanced fragment analysis-based individualized subtype classification of pediatric acute lymphoblastic leukemia. Scientific Reports. 5(1). 12435–12435. 11 indexed citations
15.
Wang, Kai‐Ling, Lei Cui, Chao Gao, et al.. (2014). [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].. PubMed. 22(2). 285–90. 1 indexed citations
16.
Ma, Xiaoli, Jie Zheng, Mei Jin, et al.. (2014). Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.. PubMed. 7(7). 4552–6. 9 indexed citations
17.
Cui, Lei, Chao Gao, Ruidong Zhang, et al.. (2014). Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol. Leukemia Research. 39(2). 115–123. 13 indexed citations
19.
Liu, Shuguang, Zhigang Li, Lei Cui, et al.. (2011). Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population. Leukemia & lymphoma. 52(6). 1030–1040. 44 indexed citations
20.
Li, Weijing, et al.. (2005). Impacts of Barotropic and Baroclinic Enstrophy Interaction on Ural Blocking Processes. Gaoyuan qixiang. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026